Loss of regulation of circulating 1,25-dihydroxyvitamin D with paradoxically decreased serum phosphate levels in individuals with recurrent kidney stones

Urological Research

Volumn 28, Issue 3, 2000, Pages 155-158

  Yamakawa, K ^a   Franco Coronel, O E ^a   Ohnishi, T ^a   Suzuki, R ^a   Satani, H ^a   Kawamura, J ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,25 Dihydroxyvitamin D; Hypercalciuria; Normocalciuria; Phosphate; Recurrence of kidney stone formation; Stone formers

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCALCIURIA; HYPOPHOSPHATEMIA; MALE; NEPHROLITHIASIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RECURRENT DISEASE; STONE FORMATION; VITAMIN D METABOLISM;

ADULT; AGED; CALCITRIOL; CALCIUM; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PHOSPHATES; PREDICTIVE VALUE OF TESTS; RECURRENCE;

EID: 0033934470     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002409900071     Document Type: Article

References (24)

1. Yoshida O, Okada Y (1990) Epidemiology of urolithiasis in Japan: A chronological and geographical study. Urol Int 9: 104
2. Sierakowski R, Finlayson B, Landes RR, Finlayson CD, Sierakowski N (1978) The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 15: 438
3. Andersen DA (1969) Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. In: Hodgkinson A, Nordin BEC (eds) Renal stone symposium. Churchill, London, p7
4. Norlin A, Lindell B, Granberg PO, Lindvall N (1976) Urolithiasis: A study of its frequency. Scand J Urol Nephrol 10: 150
5. Coe FL, Keck J, Norton ER (1977) The natural history of calcium urolithiasis. JAMA 238: 1519
6. Ungeman JE, Smith LH, Woods JR, Newman DM (1989) Urinary Calculi: ESWL, Endourology and Medical Therapy. Lea and Febiger, Philadelphia
7. Wikstrom B, Backman U, Danielson BG, Fellstrom B, Johansson G, Ljunghall S, Wide L (1981) Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. Scand J Urol Nephrol Suppl 61: 11: 1
8. Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Crystal Growth 53: 166
9. Portale AA, Hallonran BP, Moris RC Jr (1989) Physiological regulation of the serum concentration of 1.25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83: 1494
10. Hamada N, Miura T, Suzuki A, Noh J, Takazawa J, Lijima T (1989) Serum parathyroid hormone concentration measured by highly sensitive assay in post-thyroidectomy hypocalcemia of patients with Graves' disease, Endocr J 36: 281
11. Watanabe Y, Kubota T, Suzumura E, Suzuki T, Yonezawa M, Ishigami T (1994) 1,25-dihydroxyvitamin D radioreceptor assay using bovine mammary gland receptor and non-high performance liquid Chromatographic purification. Clin Chim Acta 225: 187
12. Raisz LG, Kream BE, Lorenzo JA (1998) Metablic bone disease. In Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams textbook of endocrinology. Saunders, Philadelphia, p 1211
13. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755
14. Lida K, Shinki T, Yamaguchi A, DeLuca H, Kurokawa K, Suda T(1995) A possible role of vitamin D receptors in regulating vitamin D activation in the kidney. Proc Natl Acad Sci USA 92: 6112
15. Kumar R (1980) The metabolism of 1,25-dihydroxyvitamin Dg, Endocr Rev 1: 258
16. Pak CYC (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18: 624
17. Breslau NA, Preminger GM, Beverley VA, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75: 1446
18. Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311: 73
19. 3-mediated upregulation. In: Pak CYC, Resnick M1, Preminger GM (eds) Proceedings of the Eighth International Symposium Urolithiasis. Millet The Printer, Dallas, p 546
20. Gray RW, Wilz DR, Caldas AE, Lemann J Jr (1977) The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 45: 299
21. Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR (1977) Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 90: 955
22. Ulmann A, Aubert J, Bourdeau A, Cheynel C, Bader C (1982) Effects of weight and glucose ingestion on urinary calcium and phosphate excretion: implications for calcium nephrolithiasis. J Clin Endocrinol Metab 54: 1063
23. van Den Berg CJ, Kumar R, Wilsom DM, Heath H, Smith LH (1980) Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 51: 998
24. Levy FL, Adams-Huet B, Pak CYC (1995) Ambulatory evaluation of nephrolithiasis: An update od a 1980 protocol. Am J Med 98: 50